Siemens completes acquisition of Dotmatics
July 1, 2025
Acquisition successfully closed for enterprise value of $5.1 billion Siemens expands AI-powered Siemens Xcelerator portfolio with end-to-end digital thread that connects data from research through to production in Life Sciences Combined capabilities expected to accelerate scientific innovation and drive long-term growth Acquisition is another milestone of Siemens' ONE Tech Company program expanding Siemens' offerings into the [...]
PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan
July 1, 2025
Enabling Scalable, Non-Viral Cell Engineering for Research, Biomanufacturing, and Therapeutic Development -- TOKYO -- The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as "PHCbi"), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo, hereafter referred to as "PHCHD") announces it has signed an exclusive agreement with MaxCyte, Inc. [...]
Ad hoc announcement pursuant to Art. 53 LR — Zeochem to acquire SiliCycle of Canada
July 1, 2025
The Chemistry Division of the CPH Group has entered into an agreement to purchase all substantial assets of SiliCycle Inc., a Canada-based company. The acquisition of this manufacturer of high-value chromatography gels for the pharmaceutical industries marks a further milestone in the CPH Group’s implementation of its global expansion strategy. Perlen – The CPH Group [...]
June 30, 2025
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development and diagnostics The NATO Innovation Fund and Earlybird led a $35 million Series A round in Portal Biotech, a pioneering biotechnology company headquartered in London. This represents one of Europe’s largest investments into a life sciences tools company and positions Portal Biotech [...]
Epigenica Closes $2.2 Million Investment Round to Scale Cutting-Edge Epigenetic Solutions
June 30, 2025
Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market STOCKHOLM -- Epigenica AB, a pioneer in high-throughput epigenetic screening tools and solutions, announced today that it has closed a $2.2 million round (SEK 21.5M) to fuel its growth and commercial expansion across key markets. This round was led by Voima Ventures, a Nordic early-stage [...]
June 30, 2025
Funding to accelerate platform expansion into new applications in cell-to-cell interactions and tissue STOCKHOLM, Sweden — Pixelgen Technologies today announced that it has been awarded grant and equity financing of EUR 12.5 M ($14.7 million) from the European Innovation Council (EIC) Accelerator, a funding initiative under the European Union’s Horizon Europe program designed to support highly innovative start-ups with [...]
June 30, 2025
Strategic MOU signed with global mass spectrometry leader SCIEX SEOUL, South Korea -- SCIEX, a global leader in life science analytical technologies, signed a strategic Memorandum of Understanding (MOU) with Chungnam National University. The agreement, signed by Chris Hagen, President of SCIEX, and Kim Jung-Kyum, President of Chungnam National University, emphasizes the significance of this [...]
June 30, 2025
Combined market-leading speed and 27 channel capacity enable maximum flexibility and data generation New fluidics and clog detection systems further simplify operation and reduce instrument downtime Intuitive software supports 24 hours of continuous runtime and easy analysis of complex high-throughput datasets Göttingen, Germany -- The life science group Sartorius launches the new iQue® 5 High-Throughput [...]
Danaher Appoints Martin Stumpe as Chief Technology and AI Officer
June 27, 2025
WASHINGTON -- Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher's digital transformation and its ambition to lead the [...]
Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences
June 27, 2025
WASHINGTON -- Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025. Mr. Milosevich has served as Vice President and Group Executive of the [...]

